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ABSTRACT 
Background: We characterize a novel nanocomposite that acts as an efficient anticancer 
agent. Methods: This nanocomposite consists of zinc layered hydroxide intercalated with 
protocatechuate (an anionic form of protocatechuic acid), that has been synthesized using a 
direct method with zinc oxide and protocatechuic acid as precursors. Results: The resulting 
protocatechuic acid nanocomposite (PAN) showed a basal spacing of 12.7 Å, indicating that 
protocatechuate was intercalated in a monolayer arrangement, with an angle of 54° from the 
Z-axis between the interlayers of the zinc layered hydroxide, and an estimated drug loading 
of about 35.7%. PAN exhibited the properties of a mesoporous type material, with greatly 
enhanced thermal stability of protocatechuate as compared to its free counterpart. The 
presence of protocatechuate in the interlayers of the zinc layered hydroxide was further 
supported by Fourier transform infrared spectroscopy. Protocatechuate was released from 
PAN in a slow and sustained manner. This mechanism of release was well represented by a 
pseudo-second order kinetics model. PAN has shown increased cytotoxicity compared to the 
free form of protocatechuic acid in all cancer cell lines tested. Tumor growth suppression was 
extensive, particularly in HepG2 and HT29 cell lines. Conclusion: PAN is suitable for use as 
a controlled release formulation, and our in vitro evidence indicates that PAN is an effective 
anticancer agent. PAN may have potential as a chemotherapeutic drug for human cancer. 
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